A share price of Oncology Institute Inc [TOI] is currently trading at $2.44, up 10.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TOI shares have gain 13.49% over the last week, with a monthly amount drifted -24.92%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Oncology Institute Inc [NASDAQ: TOI] stock has seen the most recent analyst activity on May 15, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $7. On September 14, 2022, Guggenheim initiated with a Buy rating and assigned a price target of $7 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $10 on August 15, 2022.
Oncology Institute Inc experienced fluctuations in its stock price throughout the past year between $0.13 and $3.50. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Oncology Institute Inc [NASDAQ: TOI] shares were valued at $2.44 at the most recent close of the market. An investor can expect a potential return of 227.87% based on the average TOI price forecast.
Analyzing the TOI fundamentals
Trailing Twelve Months sales for Oncology Institute Inc [NASDAQ:TOI] were 403.15M which represents 10.29% growth. Gross Profit Margin for this corporation currently stands at 0.15% with Operating Profit Margin at -0.13%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.16%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -4.83 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of20.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.23 points at the first support level, and at 2.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.61, and for the 2nd resistance point, it is at 2.78.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Oncology Institute Inc [NASDAQ:TOI] is 1.79. Also, the Quick Ratio is 1.59, while the Cash Ratio stands at 0.67. Considering the valuation of this stock, the price to sales ratio is 0.56, the price to book ratio is 42.81.
Transactions by insiders
Recent insider trading involved M33 Growth I L.P., Director, that happened on Jun 05 ’25 when 0.67 million shares were sold. Director, M33 Growth I L.P. completed a deal on Jun 05 ’25 to sell 76324.0 shares. Meanwhile, Director Hively Brad sold 1.98 million shares on Jun 03 ’25.
